ABSTRACT. To study the pulmonary vasodilator selectivity of low levels of inhaled nitric oxide (NO) in a model of neonatal pulmonary hypertension, we sequentially exposed anesthetized, spontaneously breathing neonatal pigs to each of four different inspired gas mixtures: room air, room air with 25 parts per million NO, hypoxia (14% 0 2 in N2), and hypoxia with 25 parts per million NO. The room air, room air with NO, hypoxia, and hypoxia with NO exposures were of 15-min duration. The following measurements were made: mean systemic arterial, mean pulmonary arterial, and wedge pressures; thermodilution cardiac output; esophageal pressure; tracheal flow; and arterial Po2, Pc02, pH, hemoglobin, and methemoglobin. Inhalation of NO decreased pulmonary arterial pressure in both room air and hypoxia conditions (mean pulmonary arterial pressure 16 f 1 torr room air, 13 f 1 torr room air with NO, p < 0.005; and mean pulmonary arterial pressure 21 f 2 torr hypoxia, 14 f 1 torr hypoxia with NO, p < 0.005).
NO had no significant effect on systemic arterial pressure, cardiac output, dynamic lung compliance, pulmonary resistance, or the measured blood variables during either control or hypoxic conditions. The results indicate that inhaled NO was a selective pulmonary vasodilator that could effectively reverse acute hypoxic pulmonary vasoconstriction. The normoxic vasodilation produced by NO inhalation also indicates the existence of basal vasomotor tone in the anesthetized, spontaneously breathing neonatal pig. The short-term exposures used produced no detectable manifestations of toxic side effects. (Pediatr Res 35: [20] [21] [22] [23] [24] 1994) Abbreviations NO, nitric oxide PVR, pulmonary vascular resistance PPHN, persistent pulmonary hypertension of the newborn Neonatal pulmonary diseases, such as surfactant deficiency, PPHN, and bronchopulmonary dysplasia, often present with pulmonary hypertension and remain an important cause of morbidity and mortality in infants admitted to neonatal intensive care unit. No uniformly efficacious therapy exists for pulmonary hypertension despite many trials of various vasodilators, including tolazoline; chlorpromazine; nifedipine; verapamil; sodium nitroprusside; amrinone; fentanyl; sodium bicarbonate; neuromuscular blockers; and the prostaglandins I*, El, and D2 (1). An efficacious therapy would be one that resulted in a sustained decrease in pulmonary artery pressure with no change in systemic blood pressure and no change or an increase in cardiac output. Many of the vasodilators that have been used in adults with primary pulmonary hypertension were developed for the treatment of systemic hypertension, and none has proved to be a sufficiently selective pulmonary vasodilator (2) . In fact, the dose of the vasodilator is usually titrated until a predetermined fall in systemic blood pressure occurs (1, 2). The search for a selective pulmonary vasodilator has recently centered on the endothelial cell. NO has been shown to have an important role in the vasodilator response to a wide variety of agents (3-3, which has led to the concept that the administration of exogenous NO may have therapeutic potential in the treatment of pulmonary hypertensive diseases. The reaction of NO with hemoglobin inactivates the vasodilator effects of NO (6) , and the reaction with hemoglobin is so rapid (7) that NO is probably not a generally useful blood-borne vasodilator. For the pulmonary circulation, wherein NO can be delivered via the inspired air, the rapid reaction with hemoglobin may be an advantage in that inactivation in the blood could limit its vasodilator effect to those vessels that are in close apposition to the air space. For example, Frostell et al. (8) found that inhaled NO reversed hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Furthermore, studies on isolated airway segments suggest that NO may be a bronchodilator (9) . Thus inhaled NO may be particularly beneficial in lung diseases that are characterized by both vasoconstriction and bronchoconstriction, such as bronchopulmonary dysplasia. However, the enthusiasm for the therapeutic use of NO in pulmonary hypertensive disease must be tempered by the consideration of the potential for toxic side effects.
The aim of this study in neonatal animals was to determine the efficacy of inhaled NO as a selective pulmonary vasodilator and the effects of inhaled NO on lung mechanics and methemoglobin formation. Measurements were obtained during 15-min exposures to room air, to room air with 25 parts per million (ppm) NO, to hypoxia, and to hypoxia with 25 ppm NO. The neonatal pig was chosen because the pig lung has a similar postnatal morphologic development when compared with the human lung (lo), and it has been used extensively as an animal model in studies of sepsis-induced PPHN ( 1 1-14) . Studies of the efficacy of short-term exposure to NO were deemed necessary before embarking on long-term exposures such as might be relevant to the clinical setting. An important objective of this research was to develop a model for future study of the effects of longer term exposure to NO in a relevant neonatal animal.
tized with a mixture of acepromazine (1.5 mg/kg) and ketamine (30 mg/kg) given intramuscularly and then placed in the supine position on a servo-controlled heating blanket. Catheters were placed in the inferior vena cava via the femoral vein and in the descending aorta via the femoral artery. Sodium pentobarbital (4 mglkg) was administered i.v. every hour to maintain anesthesia. A tracheostomy was performed, and a 5 Fr Swan-Ganz catheter was advanced into a branch of the pulmonary artery via the right external jugular vein. The position of the Swan-Ganz catheter was determined with the pressure waveform recorded from the distal tip of the catheter and confirmed at autopsy.
The mean pulmonary arterial (Pa) and mean systemic arterial pressures were measured continuously, and the pulmonary wedge (Pw) pressure was measured during each experimental condition.
Cardiac output was measured by the bolus injection of 2 mL of iced saline into the femoral venous line, and the thermodilution cardiac output was calculated using a cardiac output computer (model 9520, American Edwards, Santa Ana, CA). The reported values for cardiac output are the average of three injections under each condition. PVR was calculated as (Pa -Pw)
The tracheostomy tube was attached to a pneumotachograph. The flow signal was recorded and also integrated for the determination of volume. An esophageal balloon was placed in the lower one-third of the esophagus for measurement of pressure. The flow, volume, and esophageal pressure signals were digitized at 50 Hz and used to calculate dynamic compliance and pulmonary resistance using the method of Dennis et al. (15) .
Arterial blood gases were determined using a blood gas analyzer (Ciba-Corning model 278, Coming Medical, Medfield, MA). Hemoglobin concentration was quantified using the standard cyanornethemoglobin method. Hematocrit was determined in the standard fashion. Methemoglobin was determined in triplicate by the method of Fairbanks and Klee (16) . Briefly, 0.1 mL of blood was hemolyzed using distilled water, and then 4 mL of a phosphate buffer (pH 6.6) was added. Three mL of this solution was divided between two cuvettes (C2 and C3). To C3, 0.1 ml of 0.6 M potassium ferricyanide was added, and after 2 min the absorbance of C2 and C3 were read at 630 nm (A2, and A, . , respectively). Then 0.1 mL of 0.8 M potassium cyanide was added to both C2 and C3, and the absorbance was read at 630 nm (A2b and A3b, respectively). The phosphate buffer was used as the blank for all absorbance readings. The percentage methemoglobin (%Mb) was then Nitric oxide gas was synthesized according to the method described by Schenk (17) . Briefly, alternate layers of 8.5 g of finely ground anhydrous ferrous sulfate and a finely pulverized mixture of 8.5 g of sodium bromide and 4 g of sodium nitrite were placed in a dry, 100-mL round bottom flask. One drop of distilled water was added to initiate the reaction, and then the flask was shaken and the gas collected in a gas syringe after discarding the first 100 mL of gas. The NO was always handled in a hood to avoid exposing personnel to either NO or NO2.
Four gas mixtures were used: 2 1 % O2 in N2, which we termed room air, room air with 25 pprn NO (referred to as room air with NO), 14% 0 2 in Nz, which we termed hypoxia, and hypoxia with 25 pprn NO (referred to as hypoxia with NO). The room air and hypoxia gas mixtures were made with calibrated flow meters and stored in gas bags. The room air with NO and hypoxia with NO gas mixtures were made by first filling a gas bag with the appropriate volumes of N2 and then adding the appropriate volume of NO using a gas syringe. Finally, the appropriate volume of 0 2 was added within 10 min of use with a calibrated flow meter. The bags were always filled in this manner to avoid exposing high concentrations of NO to O2 and thus avoid the oxidation of NO to N02. The NO2 concentrations of the room air with NO and hypoxia with NO bags were measured over time using the technique described by Saltzman ( 1 8). Less than 1 pprn NO2 was present in the room air with NO and hypoxia with NO bags even after 5 h. The gas mixtures were administered via a nonrebreathing valve that was attached to the pneumotachograph. The exhaled gas was collected for determination of CO2 and O2 concentrations. The exhaled concentrations of C02 and 0 2 were then used to calculate 0 2 uptake, CO2 production, and, along with the arterial Pcoz, the physiologic dead space.
While the pig was spontaneously breathing, hemodynamic measurements, lung mechanics measurements, and arterial blood samples were obtained during baseline conditions with room air being breathed. The breathing gas was then changed to room air with NO. After 15 min, the measurements described above were repeated, and the gas was changed to room air. After it was on room air for 2 or 3 min, when pulmonary artery pressure had stabilized at the baseline value, the gas was switched to hypoxia. After the gas was on hypoxia for 15 min, the measurements described above were repeated, and the gas was changed to hypoxia with NO. After 15 min the measurements described above were repeated. We have previously found that the neonatal pig has a stable hypoxic response over this time period (19) . Finally, the pig breathed room air, and after 2 or 3 min, when the pulmonary artery pressure had stabilized at the baseline value, the pig was exsanguinated and the lungs removed for the determination of wet-to-dry weight ratios.
The data are presented as the mean + SEM. The t test for paired data was used to compare the changes that occurred during the different experimental conditions. The p values are given whenp < 0.05. In making the three comparisons we are interested in (i.e. room air to room air with NO, hypoxia to hypoxia with NO, and room air to hypoxia), the Bonferroni method indicates a significance level of p < 0.0 17 for rejecting the null hypothesis.
RESULTS
In the spontaneously breathing neonatal pig, reducing the inspired oxygen tension produced a significant decrease in PO2 in the two hypoxic conditions compared with the two room air conditions. Otherwise, no significant change occurred in PO2, Pco2, or pH between room air and room air with NO or between hypoxia and hypoxia with NO. The mean of the pulmonary arterial pressure tracing for all seven animals is shown in Figure  1 . Each of the seven pigs responded in a similar fashion, that is, when 25 pprn NO was added to the room air mixture, a decrease in mean pulmonary arterial pressure occurred, and when the gas mixture was changed to the hypoxia mixture an increase in mean pulmonary arterial pressure occurred. Furthermore, this hypoxia-induced increase in mean pulmonary arterial pressure was essentially reversed by adding 25 pprn NO to the hypoxic gas mixture in each pig studied. Because these changes in mean pulmonary arterial pressure occurred with no significant changes in cardiac output or wedge pressure (Table I) , the changes in mean pulmonary arterial pressure reflect changes in PVR (also given in Table 1 ). The pattern of the PVR response in each individual animal was also the same as the mean response. Figure  2 shows the mean for all seven animals for the pulmonary and systemic hemodynamic responses after 15 min in each condition. Again, it can be seen that adding NO to the inspired gas mixture caused pulmonary vasodilation under both baseline and hypoxic conditions. This representation of the data emphasizes that no significant systemic effects were detected.
Tidal volume, minute ventilation, dead space, respiratory rate, oxygen uptake, and carbon dioxide production were unaffected by the experimental condition (Table I) . Inhaled NO (25 ppm) had no significant effect on the airways during either control or hypoxic conditions, as evidenced by no significant change in either dynamic lung compliance or pulmonary resistance (Table   22 NELIN ET AL. Table 1 were stable during the course lin). Studies from isolated, perfused neonatal pig lungs also of the experiment and are comparable to values previously suggest the presence of basal vasomotor tone. For example, Fike reported in neonatal pigs (20) (21) (22) (23) . As a positive control in two and Kaplowitz (28) found that injection of papaverine resulted animals at the end of the experiment, 0.3 mg/kg neostigmine in a decrease in PVR in neonatal pig lungs, and we found that was given i.v., which resulted in a doubling of pulmonary resist-infusion of acetylcholine decreased PVR in a similar preparation ance from 4.0 * 1.1 cm H20/mL/s baseline to 7.8 k 2.8 cm (19) . These differences between pigs and lambs may suggest H20/mL/s after neostigmine administration. possible species differences in the level of basal pulmonary vaTable 1 also shows that no significant changes occurred in the somotor tone. The existence of such species differences is conhemoglobin, hematocrit, or methemoglobin levels during any of sistent with a recent study wherein pigs had higher tone at a the 15-min experimental conditions or during the course of the partial pressure of oxygen in the alveoli of 1 10 torr than either study. As a positive control in one animal at the end of the horses or dogs (29). On the other hand, the differences might experiment, 1000 ppm NO in room air was administered for 15 reflect other experimental aspects, such as different anesthetic min, which resulted in an increase in the methemoglobin fraction regimens. Although Worek et al. (30) found that ketamine or to 20% of the total hemoglobin. pentobarbital anesthesia did not affect hemodynamics in intact pigs, previous investigators (10, 1 1, 13) have reported baseline mean pulmonary arterial pressure-pulmonary wedge pressure in neonatal pigs ranging from 10 f 4 to 16 f 4 tom, similar to those reported in this study.
The selectivity of inhaled NO may be caused in part by its normally short tlh in solution, which has been reported to be approximately 4 s in oxygenated, hemoglobin-free media (6) . This period of time is on the order of the transit time from the pulmonary veins to the systemic arteries, and thus not much NO would be expected to survive the transit. However in addition, NO reaching the blood will rapidly combine with hemoglobin (7). The NO binding affinity for hemoglobin is much greater than that of either 0 2 or CO, and the reaction rate of NO with hemoglobin is faster than that of either CO or O2 with hemoglobin (7). Thus any NO reaching the blood would be rapidly inactivated, and the action of NO would be essentially limited to those vascular smooth muscle cells that were in close apposition to alveolar air.
One concern for potential lung toxicity of inhaled NO is based on the propensity of NO to be converted to NO2 in the presence of oxygen (3 1). NO2 is classified as a deadly poison and is highly toxic to the lungs (32), and exposure to NO2 rapidly leads to increased airway resistance, pulmonary edema, and bronchopneumonia, which may develop into bronchiolitis obliterans (33). Stavert and Lehnert (3 1) found increases in lung gravimetric measurements after a 30-min exposure to 50 pprn NO2. Miiller et al. (34) found that exposure to only 10 pprn NO2 in adult rats for 72 h led to a severe interstitial infiltrate and alveolar exudate. The lung wet weights measured in our study suggest little or no accumulation of extravascular fluid during the experimental protocol when compared with published results (20, 28) .
NO has been reported to relax isolated tracheal rings (9), and recently we found that inhaled NO (25 ppm) resulted in a decrease in pulmonary resistance in the neonatal pig lung preconstricted with neostigmine (35). In the present study, we did not detect a change in pulmonary resistance in association with inhalation of the NO, a result consistent with that of Zayek et al. (36) in neonatal lambs. This finding may be because these animals had little basal airway smooth muscle tone or because the NO concentration was insufficient. Thus this study does not provide conclusive information regarding this aspect of the possible impact of NO inhalation. On the other hand, NOz is an irritant gas that can cause bronchoconstriction (33, 37-39). The lack of a detectable bronchoconstrictor effect suggests that if any conversion of NO to NO2 occurred within the airways it was not sufficient to manifest itself in this manner.
In the present short-term study, wherein inspired gas NO2 contamination does not appear to have been a problem, it is not surprising that the various manifestations of NO2 toxicity were not detected. However, under the conditions encountered in the intensive care nursery, inhaled NO might have to be administered for at least 3 d and perhaps as many as 14 d and with elevated inspired Po*. Under such conditions the possibility that inhaled NO might be associated with these and other toxic effects of NO2 inhalation, such as decreased resistance to respiratory infections (37), will need to be evaluated. The latter may have implications in the use of inhaled NO for the treatment of infectious causes of PPHN such as group B streptococcus.
Some evidence exists that inhaled NO itself may cause lung toxicity without conversion to NO2, but this is less clear. Stavert and Lehnert (31) found that when NO was given without contamination by NO2 there was no histologic evidence of lung damage with 15-min exposures of up to 1500 ppm. In mice it was found that long-term exposure (2 wk) to 10 pprn NO led to increased lung weight and morphologic evidence of lung damage (40). Because NO has a single unpaired electron (4 I), it has been suggested that it may be involved in free radical injury to the lung. Conversion to the highly toxic peroxynitrite anion is one possibility (42-44). This potential for free radical injury might be of particular concern in the treatment of PPHN in patients receiving high concentrations of supplemental oxygen.
A potential systemic toxic effect of inhaled NO is the formation of methemoglobin. NO and its immediate oxidation product, nitrite ion, react with hemoglobin to form methemoglobin. Toothill (45) found that exposure of adult dogs to 1000 pprn to 2000 pprn NO resulted in death within 4 h as a result of methemoglobinemia. Stavert and Lehnert (3 1) found that 55% of rats exposed to 1000 pprn NO for 30 min died during or within 30 min after the exposure period because of methemoglobinemia. Maeda et a/. (46) found that exposure of adult rats to 200 pprn NO for 3 h resulted in methemoglobin levels of 40%. Recently, increases in methemoglobin levels have been reported in neonatal pigs (24) and neonatal lambs (36) exposed to 150 pprn and 100 ppm, respectively, of NO for 30 min. We found no significant change in methemoglobin levels in our pigs during 15-min exposures to inhaled NO. We did not measure the NO uptake in these studies. However, the volume of inhaled NO is a secure upper boundary on the amount of NO that could have entered the blood. Thus, if all of the inspired NO had reacted with hemoglobin, it would have increased the methemoglobin by only about 3% of the hemoglobin concentration over the 15-rnin period. Given this point as an upper boundary and the presence of the normal methemoglobin-reducing mechanisms in the blood (45) , the lack of an increase in methemoglobin in these short exposures is not a surprising result. However, there may be a dose and time effect of inhaled NO on both the formation of methemoglobin and its reduction to hemoglobin (24, 36, 46) . Therefore further studies will be required to determine methemoglobin formation under conditions similar to those that would be expected in the clinical use of inhaled NO.
In conclusion, we found that in the anesthetized, spontaneously breathing neonatal pig the inhalation of 25 pprn NO caused pulmonary vasodilation under control conditions and reversed hypoxic pulmonary vasoconstriction. This finding suggests that in this preparation basal pulmonary vasomotor tone exists that can be overcome with exogenous NO and that the acute pulmonary vasoconstriction associated with low oxygen ventilation can be reversed by NO administered via the airways.
NELIN ET AL.
The short-term inhalation of 25 ppm NO was not associated with detectable toxic side effects. This finding suggests that further studies into the use of inhaled NO as a pharmacologic tool in neonatal pulmonary hypertensive diseases such as PPHN are warranted. It appears that the neonatal pig preparation that we describe will be a useful animal model for such studies.
